WBP Home WBP Home
 
About Us Issues Our Work Get Involved News & Events
WBP Home
 
 
Women and Bioethics

Women’s perspectives and life experiences are not adequately represented in current bioethical debate, public policy decisions, or academic research. The realities of women’s lives are different from men’s—socially, politically, and economically. By and large women are the world’s caretakers, caring for the young, the old, and the sick in communities all over the globe. Relative to men, women are politically disenfranchised and economically dependent. Women’s access to healthcare, including contraception and prenatal care, is subject to outside control in a way that men’s is not. Likewise, women’s bodies are different from men’s.

Yet the majority of those leading the public debate are men. Women can neither rely on, nor expect, men to represent the entire range of human experience and perspectives. Although several other women’s policy institutes exist, not one is focused on bioethics. It’s not that they aren’t concerned about bioethical issues; it’s just that their resources are stretched. The bottom line is that women’s policy institutes just aren’t funded at the level that conservative think tanks are. In this absence of rigorous, accessible, and thorough scholarship focused through the lens of women’s experience, women risk not being considered or heard on complex bioethical issues.

Many bioethical issues have different and disproportionate effects on women’s lives—effects that current policy does not take into account. For example, women have been excluded from heart disease studies until recently. As a result, many women who were presenting in the emergency room with heart attacks were misdiagnosed because their symptoms and risk factors were different from those of men. Because physicians did not have the information they needed to treat their patients, countless women did not receive the life-saving care they needed. This information gap resulted in many deaths, with families suffering the needless loss of a mother, sister, or daughter.

The gynecological health of HIV-positive women was also not studied until recently. As in heart disease, AIDS looks different in women. Early symptoms in women with AIDS include pelvic inflammatory disease, cervical cancer, or abdominal pain, whereas men often present first with sarcoma and other symptoms. Consequently, HIV-positive women in this country—who are often drug users, poor, and minority women—have not received the same level of care as men. Delayed diagnosis makes many AIDS patients ineligible for life-saving drugs and other supportive services.

Analysis that takes into account the realities of women’s lives offers a new perspective on familiar questions. For example, surrogate decision-making (in which a previously designated person speaks on behalf of the patient) is the standard model for patients who are unable to make their own choices about their medical treatment. Considering this model from a gender perspective, and taking into account other relevant facts—for instance, the average age of widowhood in the U.S. is 55, meaning that there are women with many years left to live who have lost the person who may have been their best proxy-we begin to see why gender-based differences must be considered in policy formulation.

Reproductive issues are central to any discussion of bioethics and women. For decades Americans have been engaged in the pro-choice versus pro-life debate. But what does that mean in light of biotechnological advancements? For example, who decides the fate of a frozen embryo if the parents cannot reach agreement? What if the father wants the embryo destroyed, but the mother wants it implanted into her uterus—or someone else’s? The established terms of debate do not accommodate such emerging questions. Currently, these decisions are being made by the courts, without the benefit of public debate or legislative oversight.

We tend to think of surrogate motherhood as a non-economic exchange, in which a woman has a baby for an infertile friend or family member. The surrogate is artificially inseminated by the father’s sperm, carries the child, and then turns the child over to the couple. However, with assisted reproductive technology, it is now possible to harvest an egg from one woman, fertilize it outside the womb, and then implant it into a surrogate womb for gestation. Certain states prohibit surrogacy contracts, but others, such as California, allow them. An unintended consequence of all this is that increasingly, minority and immigrant women are serving as “host wombs” for wealthy white couples. Is that reproductive freedom or is it economic exploitation?

Babies can now survive outside the womb at 24 weeks, and scientists expect that number to decrease. What if technology allowed us to perform an “eviction” instead of an abortion, so that we could safely remove the fetus without destroying it and implant it into another woman or an artificial womb? Under what circumstances would we compel a woman to have one procedure instead of the other? These are not science-fiction scenarios; we must have the courage to tackle these issues, ask hard questions, and be creative with our solutions.

For most of history, positions of power and seniority have been occupied by men. Men have set research agendas, chosen funding priorities, written laws and public policy, and determined which questions are worthy of attention. These decisions affect all of us—not only men. Women must have a place at the table to influence policy and protect their interests.
 
   
 
Home | Blog | Contact Us | Get Involved | Site Map | FAQ | Privacy Policy | Donate

© Women’s Bioethics Project
4616 25th Avenue NE, Suite 556
Seattle, WA 98105
(206) 200-1101
FAX: (206) 568-8313
info@womensbioethics.org